HKMPF News and Press, Hikma Pharmaceuticals Plc From 03/13/19

Hikma Pharmaceuticals PLC (HKMPF) Q4 2018 Earnings Conference Call March 13, 2019 05:30 AM ET Company Participants Siggi Olafsson - Chief Executive Officer Khalid Nabilsi - Chief Financial Officer Conference Call Participants James Gordon - JP Morgan Max Hermann - Stifel ...

The following slide deck was published by Hikma Pharmaceuticals PLC in conjunction with their 2018 Q4 earnings Read more ...

For a good chunk of 2018, the UK's equity markets were under the cosh, and index prices fell across the board. But, since the start of this year, there's been a sense of optimism around. Political and economic uncertainties aside, the FTSE All-Share has managed a 6.8 percent gain in recent wee...

The following slide deck was published by Hikma Pharmaceuticals plc. in conjunction with this Read more ...

Hikma Pharmaceuticals ( OTCPK:HKMPF +9.3% ) agrees to acquire Medlac Pharma, an injectable manufacturing company in Vietnam More news on: Hikma Pharmaceuticals plc., Hikma Pharmaceuticals plc. ADR, Merger & acquisition news, Healthcare stocks news, Read more ...

Hikma Pharmaceuticals plc. (HKMPF) Q2 2018 Earnings Conference Call August 15, 2018 04:30 AM ET Executives Said Darwazah - Executive Chairman Siggi Olafsson - CEO Khalid Nabilsi - CFO Analysts James Vane-Tempest - Jefferies Pete Verdult - Citi Amy Walker - Peel Hunt M...

The following slide deck was published by Hikma Pharmaceuticals plc. in conjunction with their 2018 Q2 earnings Read more ...

Hikma Pharmaceuticals ( OTCPK:HKMPF ): 1H EPS of $0.61 More news on: Hikma Pharmaceuticals plc., Earnings news and commentary, Healthcare stocks news, Read more ...

Read more ...

Read more ...